Literature DB >> 16849522

Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.

Nabendu Pore1, Zibin Jiang, Hui-Kuo Shu, Eric Bernhard, Gary D Kao, Amit Maity.   

Abstract

The phosphoinositide 3-kinase (PI3K)/Akt pathway is commonly activated in cancer; therefore, we investigated its role in hypoxia-inducible factor-1alpha (HIF-1alpha) regulation. Inhibition of PI3K in U87MG glioblastoma cells, which have activated PI3K/Akt activity secondary to phosphatase and tensin homologue deleted on chromosome 10 (PTEN) mutation, with LY294002 blunted the induction of HIF-1alpha protein and its targets vascular endothelial growth factor and glut1 mRNA in response to hypoxia. Introduction of wild-type PTEN into these cells also blunted HIF-1alpha induction in response to hypoxia and decreased HIF-1alpha accumulation in the presence of the proteasomal inhibitor MG132. Akt small interfering RNA (siRNA) also decreased HIF-1alpha induction under hypoxia and its accumulation in normoxia in the presence of dimethyloxallyl glycine, a prolyl hydroxylase inhibitor that prevents HIF-1alpha degradation. Metabolic labeling studies showed that Akt siRNA decreased HIF-1alpha translation in normoxia in the presence of dimethyloxallyl glycine and in hypoxia. Inhibition of mammalian target of rapamycin (mTOR) with rapamycin (10-100 nmol/L) had no significant effect on HIF-1alpha induction in a variety of cell lines, a finding that was confirmed using mTOR siRNA. Furthermore, neither mTOR siRNA nor rapamycin decreased HIF-1alpha translation as determined by metabolic labeling studies. Therefore, our results indicate that Akt can augment HIF-1alpha expression by increasing its translation under both normoxic and hypoxic conditions; however, the pathway we are investigating seems to be rapamycin insensitive and mTOR independent. These observations, which were made on cells grown in standard tissue culture medium (10% serum), were confirmed in PC3 prostate carcinoma cells. We did find that rapamycin could decrease HIF-1alpha expression when cells were cultured in low serum, but this seems to represent a different pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849522     DOI: 10.1158/1541-7786.MCR-05-0234

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  85 in total

1.  Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.

Authors:  Jessica M Cassavaugh; Sarah A Hale; Theresa L Wellman; Alan K Howe; Cheung Wong; Karen M Lounsbury
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

2.  Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.

Authors:  Hirotoshi Kikuchi; Maria S Pino; Min Zeng; Senji Shirasawa; Daniel C Chung
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

3.  Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.

Authors:  Richa Tewari; Saurav Roy Choudhury; Sadashib Ghosh; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2011-09-02       Impact factor: 4.599

4.  Time-of-Day Dependent Neuronal Injury After Ischemic Stroke: Implication of Circadian Clock Transcriptional Factor Bmal1 and Survival Kinase AKT.

Authors:  Mustafa Caglar Beker; Berrak Caglayan; Esra Yalcin; Ahmet Burak Caglayan; Seyma Turkseven; Busra Gurel; Taha Kelestemur; Elif Sertel; Zafer Sahin; Selim Kutlu; Ulkan Kilic; Ahmet Tarik Baykal; Ertugrul Kilic
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

5.  The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation.

Authors:  George J Cerniglia; Souvik Dey; Shannon M Gallagher-Colombo; Natalie A Daurio; Stephen Tuttle; Theresa M Busch; Alexander Lin; Ramon Sun; Tatiana V Esipova; Sergei A Vinogradov; Nicholas Denko; Constantinos Koumenis; Amit Maity
Journal:  Mol Cancer Ther       Date:  2015-05-20       Impact factor: 6.261

6.  Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.

Authors:  Vivek Sharma; Deobrat Dixit; Nitin Koul; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2010-09-24       Impact factor: 4.599

7.  Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.

Authors:  Javier A Menendez; Tomás Alarcón; Jorge Joven
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

8.  N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Authors:  J Kang; P G Rychahou; T A Ishola; J M Mourot; B M Evers; D H Chung
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

9.  Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.

Authors:  Armina A Kazi; Kristin Happ Molitoris; Robert D Koos
Journal:  Biol Reprod       Date:  2009-05-06       Impact factor: 4.285

10.  A dialogue between the hypoxia-inducible factor and the tumor microenvironment.

Authors:  Frédéric Dayan; Nathalie M Mazure; M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.